CNBC October 27, 2020
Key Points
– Drug supply chains are often global with China being the world’s largest supplier of active pharmaceutical ingredients.
– Fujifilm Diosynth Biotechnologies is working with developer Novavax to manufacture a Covid-19 vaccine.
– Martin Meeson, CEO of Fujifilm Diosynth Biotechnologies, told CNBC’s “Squawk Box Europe” that drug companies were working to make sure people had access to medicine.
Drug supply chains may become less global as a result of the pandemic, according to the chief executive of a pharmaceutical manufacturer.
Martin Meeson, CEO of Fujifilm Diosynth Biotechnologies, told CNBC’s “Squawk Box Europe” that drug companies were working to make sure people had access to medicine.
“I think there might be a slightly more local focus as we...
Today's Sponsors
Today's Sponsor